Gregory Divis | executive |
Richard Kim | executive |
Jennifer Gudeman | executive |
Thomas McHugh | executive |
Lin Tsai | analyst |
François Brisebois | analyst |
Ami Fadia | analyst |
David Amsellem | analyst |
Marc Goodman | analyst |
Oren Livnat | analyst |
Myriam Belghiti | analyst |
Matthew Kaplan | analyst |
Greetings, and welcome to Avadel Pharmaceuticals Second Quarter 2024 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded.
It is now my pleasure to introduce Austin Murtagh with Precision AQ. Thank you.
You may begin.